Viewing Study NCT01419834


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2025-12-28 @ 12:06 AM
Study NCT ID: NCT01419834
Status: COMPLETED
Last Update Posted: 2023-08-04
First Post: 2011-08-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module